Dr. Masataka Kusunoki
ProfessorNagoya University, Japan
Highest Degree
Ph.D. in Clinical Immunology from Aichi Medical University, Japan
Share this Profile
Area of Interest:
Selected Publications
- Sato, D., K. Oda, M. Kusunoki, A. Nishina and K. Takahashi et al., 2016. PPARγ activation alters fatty acid composition in adipose triglyceride, in addition to proliferation of small adipocytes, in insulin resistant high-fat fed rats. Eur. J. Pharmacol., 773: 71-77.
CrossRef | Direct Link | - Kusunoki, M., Y. Natsume, D. Sato, H. Tsutsui and T. Miyata et al., 2016. Luseogliflozin, a sodium glucose co-transporter 2 inhibitor, alleviates hepatic impairment in Japanese patients with type 2 diabetes. Drug Res., 66: 603-606.
CrossRef | PubMed | Direct Link | - Kusunoki, M., D. Sato, T. Nakamura, Y. Oshida and H. Tsutsui et al., 2016. The beneficial effects of the DPP-4 inhibitor alogliptin on hemoglobin A1c and serum lipids in Japanese patients with type 2 diabetes. Drug Res., 66: 18-22.
CrossRef | PubMed | Direct Link | - Sato, D., M. Kusunoki, G. Shinzawa, Z. Feng, A. Nishina and T. Nakamura, 2015. Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats. Autonomic Neurosci.: Basic Clin., 193: 69-73.
CrossRef | Direct Link | - Kusunoki, M., D. Sato, T. Nakamura, Y. Oshida and H. Tsutsui et al., 2015. DPP-4 inhibitor teneligliptin improves insulin resistance and serum lipid profile in Japanese patients with type 2 diabetes. Drug Res., 65: 532-534.
CrossRef | PubMed | Direct Link | - Kusunoki, M., D. Sato, K. Tsutsumi, H. Tsutsui, T. Nakamura and Y. Oshida, 2015. Black soybean extract improves lipid profiles in fenofibrate-treated type 2 diabetics with postprandial hyperlipidemia. J. Med. Food, 18: 615-618.
CrossRef | Direct Link | - Chen, T., M. Kusunoki, D. Sato, H. Tsutsui, T. Nakamura, T. Miyata and Y. Oshida, 2013. Clinical effect of addition of beraprost sodium to pioglitazone treatment on the blood glucose levels in patients with type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes, 121: 624-627.
CrossRef | PubMed | Direct Link | - Sato, D., T. Nakamura, K. Tsutsumi, G. Shinzawa and T. Karimata et al., 2012. Site dependency of fatty acid composition in adipose triacylglycerol in rats and its absence as a result of high-fat feeding. Metab.: Clin. Exp., 61: 92-98.
CrossRef | Direct Link | - Kusunoki, M., K. Tsutsumi, D. Sato, A. Nakamura and S. Habu et al., 2011. Activation of lipoprotein lipase increases serum high density lipoprotein 2 cholesterol and enlarges high density lipoprotein 2 particles in rats. Eur. J. Pharmacol., 668: 337-339.
CrossRef | Direct Link | - Kusunoki, M., K. Tsutsumi, D. Sato, A. Nakamura and S. Habu et al., 2011. Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886. Eur. J. Pharmacol., 668: 486-491.
CrossRef | Direct Link | - Kusunoki, M., K. Tsutsumi, K. Iwata, W. Yin and T. Nakamura et al., 2005. NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats. Metab.: Clin. Exp., 54: 1587-1592.
CrossRef | Direct Link | - Kusunoki, M., K. Tsutsumi, Y. Inoue, T. Hara and T. Miyata et al., 2004. Lipoprotein lipase activator NO-1886 improves fatty liver caused by high-fat feeding in streptozotocin-induced diabetic rats. Metab.: Clin. Exp., 53: 260-263.
CrossRef | Direct Link | - Kusunoki, M., K. Tsutsumi, T. Hara, H. Ogawa and T. Nakamura et al., 2003. Ethyl icosapentate (omega-3 fatty acid) causes accumulation of lipids in skeletal muscle but suppresses insulin resistance in OLETF rats. Metabolism, 52: 30-34.
CrossRef | Direct Link | - Kusunoki, M., K. Tsutsumi, T. Hara, H. Ogawa and T. Nakamura et al., 2002. Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat [ndash] fed rats treated with the lipoprotein lipase activator NO-1886. Metab.: Clin. Exp., 51: 792-795.
CrossRef | Direct Link | - Kusunoki, M., K. Tsutsumi, T. Hara, H. Ogawa and T. Nakamura et al., 2002. A lipoprotein lipase activator, NO-1886 prevents impaired endothelium-dependent relaxation of aorta caused by exercise in aged rats. Exp. Gerontol., 37: 891-896.
CrossRef | Direct Link | - Kusunoki, M., T. Hara, K. Tsutsumi, T. Nakamura and T. Miyata et al., 2000. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high-fat diet. Diabetologia, 43: 875-880.
CrossRef | Direct Link | - Kusunoki, M., G.J. Cooney, T. Hara and L.H. Storlien, 1995. Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486. Diabetes, 44: 718-720.
CrossRef | Direct Link | - Kusunoki, M., L.H. Storlien, J. MacDessi, N.D. Oakes, C. Kennedy, D.J. Chisholm and E.W. Kraegen, 1993. Muscle glucose uptake during and after exercise is normal in insulin-resistant rats. Am. J. Physiol.-Endocrinol. Metab., 264: E167-E172.
CrossRef | Direct Link | - Kusunoki, M., Y. Oshida, A. Iguchi, T. Iida and T. Suga et al., 1992. Influence of sympatho-adrenal system on insulin sensitivity using the euglycemic clamp technique. Diabetes Res. Clin. Pract., 17: 125-131.
CrossRef | Direct Link |